CompletedPhase 1

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

United States3 participantsStarted 2008-02

Plain-language summary

The purpose of this study is to evaluate the efficacy of tattoo removal using topical imiquimod, 5% cream in conjunction with the 1064nm Nd:YAG laser. This procedure for tattoo removal will be compared to a laser removal alone.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 2 tattoos no larger than 25cm2, professionally made, with approximately the same age, containing blue/black ink. Exclusion Criteria: * Hypersensitivity to imiquimod * Current sun tan * Use of vitamin E, non-steroid anti-inflammatory drugs, coumadin or aspirin for the past 10 days * Amateur tattoos * Pregnancy * Breast-feeding status * Immunosuppression * Auto-immune diseases.

What they're measuring

Efficacy of Tattoo Removal Using Topical Imiquimod 5% Cream

Timeframe: approximately 14 weeks

Trial details

NCT IDNCT00638651

SponsorUniversity of Miami

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-08

Results submitted2014-08-20

View on ClinicalTrials.gov More Healthy trials